Addus HomeCare’s (ADUS) Market Outperform Rating Reiterated at JMP Securities

JMP Securities reissued their market outperform rating on shares of Addus HomeCare (NASDAQ:ADUS) in a research note released on Thursday,Benzinga reports. JMP Securities currently has a $150.00 price target on the stock.

Several other analysts have also commented on ADUS. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. StockNews.com cut shares of Addus HomeCare from a “buy” rating to a “hold” rating in a report on Wednesday, February 26th. Macquarie reiterated an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a research note on Thursday, February 27th. Stephens restated an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a research note on Wednesday, March 12th. Finally, Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Addus HomeCare currently has an average rating of “Moderate Buy” and an average target price of $132.78.

Addus HomeCare Stock Performance

Shares of ADUS stock opened at $100.85 on Thursday. Addus HomeCare has a 52-week low of $87.88 and a 52-week high of $136.72. The company has a 50-day simple moving average of $101.16 and a two-hundred day simple moving average of $118.07. The company has a market capitalization of $1.83 billion, a price-to-earnings ratio of 23.08, a PEG ratio of 1.41 and a beta of 0.93.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to the consensus estimate of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. On average, sell-side analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. JPMorgan Chase & Co. grew its position in shares of Addus HomeCare by 10.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock valued at $24,371,000 after purchasing an additional 16,997 shares in the last quarter. Principal Financial Group Inc. boosted its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares during the period. Cherry Creek Investment Advisors Inc. bought a new stake in Addus HomeCare during the fourth quarter valued at $340,000. Barclays PLC grew its position in Addus HomeCare by 204.8% during the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock worth $5,783,000 after buying an additional 29,207 shares in the last quarter. Finally, Amundi increased its stake in Addus HomeCare by 185.9% in the 4th quarter. Amundi now owns 9,008 shares of the company’s stock worth $1,139,000 after acquiring an additional 5,857 shares during the last quarter. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.